Messenger ribonucleic acid vaccines against infectious diseases: current concepts and future prospects
Authors:
- 4 June 2022
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 77, 102214
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- mRNA vaccines — a new era in vaccinologyNature Reviews Drug Discovery, 2018
- Efficient Targeting and Activation of Antigen-Presenting Cells In Vivo after Modified mRNA Vaccine Administration in Rhesus MacaquesMolecular Therapy, 2017
- Functional 5′ UTR mRNA structures in eukaryotic translation regulation and how to find themNature Reviews Molecular Cell Biology, 2017
- Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trialThe Lancet, 2017
- Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large AnimalsMolecular Therapy, 2015
- mRNA-based therapeutics — developing a new class of drugsNature Reviews Drug Discovery, 2014
- History of vaccinationProceedings of the National Academy of Sciences, 2014
- In Vitro Transcription of Long RNA Containing Modified Nucleosides2012
- Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cellsBlood, 2006
- Regulation of mRNA stability in mammalian cellsGene, 2001